WA innovator has national success to develop new drug

WA innovator, A/Professor Juliana Hamzah has been awarded $750,000 to develop a ground-breaking WA drug as a first-in-class agent for effective and safe removal of plaque in blood vessels, reducing the risk of cardiovascular disease.

The Future Health Research and Innovation (FHRI) Fund’s Major Research and Innovation Application Support (MRIAS) program provided an in-principle cash commitment of $1 million to A/Professor Hamzah to support an application to the Targeted Translation Research Accelerator Drugs & Devices investment opportunity which led to A/Professor Hamzah winning a grant of $750,000.

The FHRI Fund MRIAS program provides cash commitments for applications to relevant major competitive research and innovation funding programs (External Programs) that encourage co-funding.

MRIAS aims to promote high-quality research and innovation, enable opportunities for the translation of research findings into new knowledge and improved human health and wellbeing and enhance Western Australia’s standing as a leader in health and medical research.